Cargando…
High expression of lncRNA HSD11B1-AS1 indicates favorable prognosis and is associated with immune infiltration in cutaneous melanoma
Cutaneous melanoma is an aggressive malignant cancer associated with poor prognosis. Identification of reliable biomarkers for predicting prognosis of melanoma contributes to improved clinical outcome and disease management. Long non-coding RNAs (lncRNAs) serve a crucial regulatory role of oncogenes...
Autores principales: | Liu, Kaiyuan, Zhang, Li, Li, Xiuli, Zhao, Jingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721861/ https://www.ncbi.nlm.nih.gov/pubmed/34992686 http://dx.doi.org/10.3892/ol.2021.13172 |
Ejemplares similares
-
G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1
por: Okabe, Mako, et al.
Publicado: (2022) -
Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021) -
The LncRNA XIRP2-AS1 predicts favorable prognosis in colon cancer
por: Zhou, Fengru, et al.
Publicado: (2019) -
A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma
por: Sun, Shuya, et al.
Publicado: (2022) -
Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
por: Guo, Sen, et al.
Publicado: (2022)